Bangladesh bans heartburn drug ranitidine over cancer fears
Bangladesh’s drug regulatory authority on Sunday issued a ban on sales of popular heartburn drug ranitidine while it investigates a potential cancer-causing substance in the drug.
Related articles
-
Upon My Death, Play the Following Messages
October 26, 2020 -
Career federal employees take risky and rare role in impeachment drama
November 12, 2019
